Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
Silence Therapeutics Plc - American Depository Share (SLN)
Company Research
Source: Yahoo! Finance
The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 17.4% loss over the past four weeks. Earlier this week, the company announced the publication of additional data from the phase I APOLLO study evaluating its pipeline candidate, zerlasiran (SLN360), in subjects with baseline lipoprotein(a), or Lp(a), levels at or over 150 nmol/L in the Journal of the American Medical Association. The published findings showed that treatment with zerlasiran was well-tolerated and significantly reduced Lp(a) after single and multiple dosing. This might have driven the share price rally. This company is expected to post quarterly loss of $0.23 per share in its upcoming report, which represents a year-over-year change of +34.3%. Revenues are expected to be $4.53 million, down 67.2% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirica
Show less
Read more
Impact Snapshot
Event Time:
SLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLN alerts
High impacting Silence Therapeutics Plc - American Depository Share news events
Weekly update
A roundup of the hottest topics
SLN
News
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors [Yahoo! Finance]Yahoo! Finance
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of DirectorsBusiness Wire
- Silence Therapeutics plc (NASDAQ: SLN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.MarketBeat
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) [Yahoo! Finance]Yahoo! Finance
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)Business Wire
SLN
Sec Filings
- 4/29/24 - Form 6-K
- 4/15/24 - Form 6-K
- 3/27/24 - Form SC
- SLN's page on the SEC website